131 related articles for article (PubMed ID: 11758114)
1. Graft-versus-host disease.
Nijhawan A; Drolet BA
Adv Dermatol; 2001; 17():115-39. PubMed ID: 11758114
[No Abstract] [Full Text] [Related]
2. [Graft versus host disease].
Volc-Platzer B
Hautarzt; 1992 Oct; 43(10):669-77. PubMed ID: 1428880
[No Abstract] [Full Text] [Related]
3. Helper T-lymphocyte precursor frequencies predict risks of graft-versus-host disease in bone marrow transplantation.
Batchelor JR; Schwarer AP; Yin ZJ; Barrett AJ; Goldman JM; Lechler RI
Transplant Proc; 1993 Feb; 25(1 Pt 2):1237-8. PubMed ID: 8442100
[No Abstract] [Full Text] [Related]
4. [Graft versus host disease: the most threatening complication of bone marrow transplant. Review of the literature].
Rasero L; Bonavita K; Marsullo M
Assist Inferm Ric; 2002; 21(4):211-21. PubMed ID: 12674033
[No Abstract] [Full Text] [Related]
5. Chronic graft versus host disease.
Higman MA; Vogelsang GB
Br J Haematol; 2004 May; 125(4):435-54. PubMed ID: 15142114
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
[No Abstract] [Full Text] [Related]
7. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
8. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
9. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
11. The potential utility of statins as novel weapons against graft-versus-host disease.
Namazi MR; Handjani F; Sodaifi M
Med Hypotheses; 2005; 65(6):1203-4. PubMed ID: 16139438
[No Abstract] [Full Text] [Related]
12. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
13. Regulation of OX40 gene expression in graft-versus-host disease.
Miura Y; Thoburn CJ; Bright EC; Arai S; Hess AD
Transplant Proc; 2005; 37(1):57-61. PubMed ID: 15808546
[TBL] [Abstract][Full Text] [Related]
14. [Graft-versus-host disease as the cause of symptoms mimicking Sjögren's syndrome].
Tuchocka-Piotrowska A; Puszczewicz M; Kołczewska A; Majewski D
Ann Acad Med Stetin; 2006; 52 Suppl 2():89-93. PubMed ID: 17474179
[TBL] [Abstract][Full Text] [Related]
15. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
16. Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts.
Meijer E; Bloem AC; Dekker AW; Verdonck LF
Transplantation; 2003 Jun; 75(11):1910-3. PubMed ID: 12811256
[TBL] [Abstract][Full Text] [Related]
17. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
18. Serial transplantation resulting in tolerance to an unrelated cord blood graft.
Goebel WS; Nelson RP; Brahmi Z; Gowan DJ; Towell PJ; Robertson KA; Haut PR
Transplantation; 2006 Jun; 81(11):1596-9. PubMed ID: 16770250
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated graft-versus-host disease.
Rühl H; Bein G; Sachs UJ
Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
